HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival

Over the past four decades there have been minimal improvements in outcomes for patients with osteosarcoma. New targets and novel therapies are needed to improve outcomes for these patients. We sought to evaluate the prevalence and clinical significance of the newest immune checkpoint, HHLA2, in ost...

Descripción completa

Detalles Bibliográficos
Autores principales: Koirala, Pratistha, Roth, Michael E., Gill, Jonathan, Chinai, Jordan M., Ewart, Michelle R., Piperdi, Sajida, Geller, David S., Hoang, Bang H., Fatakhova, Yekaterina V., Ghorpade, Maya, Zang, Xingxing, Gorlick, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987662/
https://www.ncbi.nlm.nih.gov/pubmed/27531281
http://dx.doi.org/10.1038/srep31154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987662/
https://www.ncbi.nlm.nih.gov/pubmed/27531281
http://dx.doi.org/10.1038/srep31154

Ejemplares similares